Paul Tudor Jones Novo Cure LTD Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Novo Cure LTD stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 78,752 shares of NVCR stock, worth $1.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

78,752

Previous 382,582 79.42%

Holding current value

$1.75 Million

Previous $6.55 Million 81.23%

% of portfolio

0.0%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.61 - $23.34 $4.74 Million - $7.09 Million	-303,830 Reduced 79.42%	78,752 $1.23 Million
Q2 2024 Aug 14, 2024	BUY	$11.83 - $24.05 $203,014 - $412,722	17,161 Added 4.7%	382,582 $6.55 Million
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $2.25 Million - $3.13 Million	181,062 Added 98.21%	365,421 $5.71 Million
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $1.11 Million - $1.58 Million	100,140 Added 118.9%	184,359 $2.75 Million
Q3 2023 Nov 15, 2023	BUY	$16.15 - $42.35 $101,260 - $265,534	6,270 Added 8.04%	84,219 $1.36 Million
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $592,947 - $1.21 Million	14,717 Added 23.27%	77,949 $3.23 Million
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $2.05 Million - $4.32 Million	36,377 Added 135.46%	63,232 $3.8 Million
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $1.72 Million - $2.29 Million	26,855 New	26,855 $1.97 Million
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $2.38 Million - $3.78 Million	42,073 New	42,073 $2.92 Million
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $212,389 - $298,440	-3,531 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $265,107 - $430,746	3,531 New	3,531 $265,000
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $615,468 - $1.03 Million	-5,298 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $690,859 - $1.2 Million	5,298 New	5,298 $1.18 Million
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $1.92 Million - $2.94 Million	-15,472 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $1.74 Million - $2.69 Million	15,472 New	15,472 $2.68 Million
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $2.02 Million - $3.87 Million	-34,795 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $1.79 Million - $2.33 Million	31,266 Added 885.97%	34,795 $2.06 Million
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $337,964 - $567,223	-5,924 Reduced 62.67%	3,529 $238,000
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $645,639 - $886,691	9,453 New	9,453 $797,000
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $1.86 Million - $2.94 Million	-30,096 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$42.22 - $63.23 $775,750 - $1.16 Million	-18,374 Reduced 37.91%	30,096 $1.9 Million
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $1.55 Million - $2.72 Million	48,470 New	48,470 $2.34 Million

Others Institutions Holding NVCR

# of Institutions

266

Shares Held

73.8M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.34B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account